BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23690107)

  • 1. Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan.
    Bakhshipour A; Mashhadi M; Mohammadi M; Nezam SK
    Acta Med Iran; 2013 May; 51(4):260-4. PubMed ID: 23690107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider.
    Bahcecioglu IH; Aygun C; Gozel N; Poyrazoglu OK; Bulut Y; Yalniz M
    J Viral Hepat; 2011 Jul; 18(7):518-24. PubMed ID: 20546500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.
    Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M
    J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran.
    Attaran MS; Sharifi Z; Hosseini SM; Samei S; Ataee Z
    APMIS; 2014 Mar; 122(3):243-7. PubMed ID: 23879563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
    Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M
    J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.
    Ho E; Deltenre P; Nkuize M; Delwaide J; Colle I; Michielsen P;
    J Med Virol; 2013 Sep; 85(9):1513-7. PubMed ID: 23852675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of hepatitis D virus infection in patients with chronic hepatitis B infection attending the three main tertiary hospitals in Libya.
    Elzouki AN; Bashir SM; Elahmer O; Elzouki I; Alkhattali F
    Arab J Gastroenterol; 2017 Dec; 18(4):216-219. PubMed ID: 29241726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
    Gheorghe L; Csiki IE; Iacob S; Gheorghe C; Trifan A; Grigorescu M; Motoc A; Suceveanu A; Curescu M; Caruntu F; Sporea I; Brisc C; Rogoveanu I; Cerban R; Tugui L; Alexandrescu A
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):413-21. PubMed ID: 26697566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran.
    Roshandel G; Semnani S; Abdolahi N; Besharat S; Keshtkar AA; Joshaqani H; Moradi A; Kalavi K; Jabbari A; Kabir MJ; Hosseini SA; Sedaqat SM; Danesh A; Roshandel D; Hedayat-Mofidi SM
    J Microbiol Immunol Infect; 2008 Jun; 41(3):227-30. PubMed ID: 18629418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases.
    Chakraborty P; Kailash U; Jain A; Goyal R; Gupta RK; Das BC; Kar P
    Indian J Med Res; 2005 Sep; 122(3):254-7. PubMed ID: 16251784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The analysis of hepatitis delta virus infective markers in the hepatitis is B virus infective people].
    Xu PS; Han SY; Sun CY; Zhao J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):307-9. PubMed ID: 23189853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India.
    Saravanan S; Velu V; Kumarasamy N; Shankar EM; Nandakumar S; Murugavel KG; Balakrishnan P; Solomon S; Thyagarajan SP
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):793-6. PubMed ID: 18556033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of hepatitis D in patients infected with hepatitis B virus in bucharest: a cross-sectional study.
    Popescu GA; Otelea D; Gavriliu LC; Neaga E; Popescu C; Paraschiv S; Fratila M
    J Med Virol; 2013 May; 85(5):769-74. PubMed ID: 23408537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization.
    Keshvari M; Alavian SM; Aghaee B; Behnava B; Mahdavi M; Fesharaki MG; Sharafi H
    Transfus Med; 2014 Dec; 24(6):411-7. PubMed ID: 25523297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California.
    Gish RG; Yi DH; Kane S; Clark M; Mangahas M; Baqai S; Winters MA; Proudfoot J; Glenn JS
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1521-5. PubMed ID: 23574043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China.
    Shen L; Gu Y; Sun L; Yang Y; Wang F; Li Y; Bi S
    J Med Virol; 2012 Mar; 84(3):445-9. PubMed ID: 22246830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.